Gonza Namulanda1, Ethel Taylor2, Mildred Maisonet3, Dana Boyd Barr4, W Dana Flanders5, David Olson2, Judith R Qualters2, John Vena6, Kate Northstone7, Luke Naeher8. 1. Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-60, Atlanta, GA 30341, USA; College of Public Health, University of Georgia, 105 Spear Rd, Athens, GA 30602, USA. Electronic address: fos0@cdc.gov. 2. Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-60, Atlanta, GA 30341, USA. 3. College of Public Health, East Tennessee State University, P O Box 70259, Johnson City, TN 37614, USA. 4. Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA. 5. Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-60, Atlanta, GA 30341, USA; Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA. 6. Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street Suite 303, MSC 835, Charleston, SC 29425, USA. 7. NIHR CLAHRC West, School of Social and Community Medicine, University of Bristol, Level 9, Whitefriars, Lewins Mead, Bristol BS1 2NT, United Kingdom. 8. Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-60, Atlanta, GA 30341, USA; College of Public Health, University of Georgia, 105 Spear Rd, Athens, GA 30602, USA.
Abstract
BACKGROUND: Evidence from experimental studies suggests that atrazine and its analytes alter the timing of puberty in laboratory animals. Such associations have not been investigated in humans. OBJECTIVE: To determine the association between in utero exposure to atrazine analytes and earlier menarche attainment in a nested case-control study of the population-based Avon Longitudinal Study of Parents and Children. METHODS: Cases were girls who reported menarche before 11.5 years while controls were girls who reported menarche at or after 11.5 years. Seven atrazine analyte concentrations were measured in maternal gestational urine samples (sample gestation week median (IQR): 12 (8-17)) during the period 1991-1992, for 174 cases and 195 controls using high performance liquid chromatography-tandem mass spectrometry. We evaluated the study association using multivariate logistic regression, adjusting for potential confounders. We used multiple imputation to impute missing confounder data for 29% of the study participants. RESULTS: Diaminochlorotriazine (DACT) was the most frequently detected analyte (58%>limit of detection [LOD]) followed by desethyl atrazine (6%), desethyl atrazine mercapturate (3%), atrazine mercapturate (1%), hydroxyl atrazine (1%), atrazine (1%) and desisopropyl atrazine (0.5%). Because of low detection of other analytes, only DACT was included in the exposure-outcome analyses. The adjusted odds of early menarche for girls with DACT exposures≥median was 1.13 (95% Confidence Interval [95% CI]:0.82, 1.55) and exposure<median was 1.01 (95% CI: 0.73, 1.42) compared to girls with exposure<LOD (reference). In the subset that excluded girls with missing data, the adjusted odds of early menarche for girls with DACT exposures≥median was 1.86 (95% CI: 1.03, 3.38) and exposure<median was 1.26 (95% CI: 0.65, 2.24) compared to the reference. CONCLUSIONS: This study is the first to examine the association between timing of menarche and atrazine analytes. We found a weak, non-significant association between in-utero exposure to atrazine metabolite DACT and early menarche, though the association was significant in the subset of girls with complete confounder information. Further exploration of the role of these exposures in female reproduction in other cohorts is needed. Published by Elsevier Inc.
BACKGROUND: Evidence from experimental studies suggests that atrazine and its analytes alter the timing of puberty in laboratory animals. Such associations have not been investigated in humans. OBJECTIVE: To determine the association between in utero exposure to atrazine analytes and earlier menarche attainment in a nested case-control study of the population-based Avon Longitudinal Study of Parents and Children. METHODS: Cases were girls who reported menarche before 11.5 years while controls were girls who reported menarche at or after 11.5 years. Seven atrazine analyte concentrations were measured in maternal gestational urine samples (sample gestation week median (IQR): 12 (8-17)) during the period 1991-1992, for 174 cases and 195 controls using high performance liquid chromatography-tandem mass spectrometry. We evaluated the study association using multivariate logistic regression, adjusting for potential confounders. We used multiple imputation to impute missing confounder data for 29% of the study participants. RESULTS: Diaminochlorotriazine (DACT) was the most frequently detected analyte (58%>limit of detection [LOD]) followed by desethyl atrazine (6%), desethyl atrazine mercapturate (3%), atrazine mercapturate (1%), hydroxyl atrazine (1%), atrazine (1%) and desisopropyl atrazine (0.5%). Because of low detection of other analytes, only DACT was included in the exposure-outcome analyses. The adjusted odds of early menarche for girls with DACT exposures≥median was 1.13 (95% Confidence Interval [95% CI]:0.82, 1.55) and exposure<median was 1.01 (95% CI: 0.73, 1.42) compared to girls with exposure<LOD (reference). In the subset that excluded girls with missing data, the adjusted odds of early menarche for girls with DACT exposures≥median was 1.86 (95% CI: 1.03, 3.38) and exposure<median was 1.26 (95% CI: 0.65, 2.24) compared to the reference. CONCLUSIONS: This study is the first to examine the association between timing of menarche and atrazine analytes. We found a weak, non-significant association between in-utero exposure to atrazine metabolite DACT and early menarche, though the association was significant in the subset of girls with complete confounder information. Further exploration of the role of these exposures in female reproduction in other cohorts is needed. Published by Elsevier Inc.
Authors: Patricia G Moorman; Rachel T Palmieri; Lucy Akushevich; Andrew Berchuck; Joellen M Schildkraut Journal: Am J Epidemiol Date: 2009-07-15 Impact factor: 4.897
Authors: Berit Bakke; Anneclaire J De Roos; Dana B Barr; Patricia A Stewart; Aaron Blair; Laura Beane Freeman; Charles F Lynch; Ruth H Allen; Michael C R Alavanja; Roel Vermeulen Journal: J Expo Sci Environ Epidemiol Date: 2008-12-03 Impact factor: 5.563
Authors: Mary S Wolff; Susan L Teitelbaum; Kathleen McGovern; Susan M Pinney; Gayle C Windham; Maida Galvez; Ashley Pajak; Michael Rybak; Antonia M Calafat; Lawrence H Kushi; Frank M Biro Journal: Environ Int Date: 2015-08-31 Impact factor: 9.621
Authors: Susan Y Euling; Marcia E Herman-Giddens; Peter A Lee; Sherry G Selevan; Anders Juul; Thorkild I A Sørensen; Leo Dunkel; John H Himes; Grete Teilmann; Shanna H Swan Journal: Pediatrics Date: 2008-02 Impact factor: 7.124
Authors: Abigail Fraser; Corrie Macdonald-Wallis; Kate Tilling; Andy Boyd; Jean Golding; George Davey Smith; John Henderson; John Macleod; Lynn Molloy; Andy Ness; Susan Ring; Scott M Nelson; Debbie A Lawlor Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Krista Yorita Christensen; Mildred Maisonet; Carol Rubin; Adrianne Holmes; Antonia M Calafat; Kayoko Kato; W Dana Flanders; Jon Heron; Michael A McGeehin; Michele Marcus Journal: Environ Int Date: 2010-09-16 Impact factor: 9.621
Authors: C S Uldbjerg; T Koch; Y-H Lim; L S Gregersen; C S Olesen; A-M Andersson; H Frederiksen; B A Coull; R Hauser; A Juul; E V Bräuner Journal: Hum Reprod Update Date: 2022-08-25 Impact factor: 17.179
Authors: Anastasia Konstantina Sakali; Alexandra Bargiota; Ioannis G Fatouros; Athanasios Jamurtas; Djuro Macut; George Mastorakos; Maria Papagianni Journal: Nutrients Date: 2021-11-22 Impact factor: 5.717
Authors: Valentina Galbiati; Erica Buoso; Roberta d'Emmanuele di Villa Bianca; Rosanna Di Paola; Fabiana Morroni; Giuseppe Nocentini; Marco Racchi; Barbara Viviani; Emanuela Corsini Journal: Front Toxicol Date: 2021-03-10
Authors: Aleksandra Fucic; Radu C Duca; Karen S Galea; Tihana Maric; Kelly Garcia; Michael S Bloom; Helle R Andersen; John E Vena Journal: Int J Environ Res Public Health Date: 2021-06-18 Impact factor: 3.390